Credit rating agency, CARE has revised rating of Vivimed Labs’ long term bank facilities worth Rs 72.36 crore to ‘BB+’ from ‘BBB-’. The rating agency has also revised rating of company’s short term bank facilities worth Rs 166.00 crore to ‘A4+’ from ‘A3’. The revision in the ratings assigned to the bank facilities of Vivimed Labs is on account of deterioration in the liquidity position of the company, leveraged capital structure, stressed debt service indicators with high repayment obligations in the medium term and decline in profitability margins in FY14 (refers to the period April 1 to March 31).
Vivimed Labs (VLL) is a listed company engaged in the business of manufacturing products (active ingredients, formulations, etc) for pharmaceutical, personal care and colour chemistry industry. VLL (Consolidated) has manufacturing facilities in India and Overseas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: